MED
#Thank you, <UNK>.
Good afternoon, everyone.
We're pleased to discuss our first quarter 2017 financial results with you today.
I will provide a brief overview of our financial and operational business performance.
Tim will then review our financial results in more detail and share our second quarter of 2017 annual guidance.
Finally, Tim and I will be available to answer your questions.
We're pleased with our start to 2017.
In the first quarter, we continued to make progress on our key strategic initiatives across our organization.
We've taken steps to position Medifast for an accelerated rate of growth with sustainable improvement in profitability as we progress through the 2017 year and over the next several years.
Revenue of $70.6 million was in line with our expectations.
Gross profit margin expanded 140 basis points, and we managed our expenses well to drive earnings of $0.51 per diluted share, which exceeded our guidance of $0.45 to $0.48 per share.
We continue to make progress in preparing Medifast for a very promising future, which includes deeper penetration of our existing U.S. market as well as expansion into new markets.
This month, we will complete a company-wide initiative focused on aligning our growth strategy, internal processes and organization to improve our efficiency and execution capability.
Our teams have already begun leveraging a broader set of resources to partner with and support our growing community of Health Coaches to achieve our growth goals.
Now let me focus on our operational performance in greater detail.
Take Shape For Life reported its 6th consecutive quarter of year-over-year growth, up 2%.
We reported 13,000 active earning Health Coaches during the quarter, an increase of 3%.
Our quarterly revenue growth rate dipped in the quarter consistent with our expectations given the slowed sponsoring we had in Q4.
We've addressed the issue and believe we are positioned to accelerate our sponsoring through the rest of the year.
The continued rollout of our new OPTAVIA-branded products and the transition of our Health Coaches to leverage the new brand identity and products is on track.
The supply chain challenges we encountered last year, resulting from strong demand, have been addressed, and we are on schedule to deliver the balance of the products ---+ of the product line at our National Convention in July.
The adoption of the OPTAVIA brand has been strong, and as we saw momentum build by mid-quarter, putting us in good place entering Q2.
We anticipate that adoption and integration of the OPTAVIA brand into our Health Coach community will continue to progress resulting in the majority of our future products revenues coming from our premium-priced OPTAVIA-branded products.
We recently hosted 2 events that demonstrated and celebrated the success we're experiencing in our Health Coach community.
Our Go Global event in the first quarter was the largest Go Global event in the history of the company.
This event, held in Atlanta during February, was held for qualifying Business Coaches who aspire to advance their business leader status.
The event featured training and collaboration forums to help Business Coaches learn the incremental skills required to help their Health Coaches advance to Business Coach status.
Build leadership development resulting from the advancement from Health Coach to Business Coach and from Business Coach to business leader is an important requirement to build sustainable growth in the coach community.
Just a couple weeks ago, we returned from our Annual Recognition Trip in Costa Rica, where we celebrated the remarkable success of our top performing Health Coaches.
I enjoyed spending the time getting to know so many of our coaches in an exciting, inspiring setting.
Their personal stories of life-long transformation were amazing, and the event should help ignite excitement through the Health Coach community as they share their experience with others on their return from a well-deserved remarkable trip.
The second quarter will be a very important quarter for Take Shape For Life.
We are regaining the momentum that slowed during the fourth quarter, and our team is working very hard to prepare for the most important convention in our history.
This convention will be a springboard for revenue growth in the back half of the year as we introduce the balance of the OPTAVIA Essential line and launch the much anticipated new business support technology platforms for our coaches.
We will also officially change the name of our Health Coach community from Take Shape For Life to OPTAVIA.
Our internal teams are in full execution mode, working side by side with our business leaders to ensure the event's success.
Early indications reflect a record attendance expected in Dallas, Texas in July for a content-packed event featuring opportunities for coaches and clients alike to embrace the OPTAVIA message, The Habits of Health system and our business opportunity to deliver our promise of offering each new client life-long transformation one healthy habit at a time.
Now let me move to Medifast Direct.
We are very pleased to see the meaningful improvements in the trajectory of our direct response business.
We've been working for quite some time to find the right balance of advertising spend, placement and messaging to ensure we have a sustainable model to acquire a growing number of customers that support our long-term profitable growth.
While we still have work to do, we're encouraged by the improving trends and anticipate more progress in the second quarter.
Our ability to acquire customers through digital sources at a reduced rate has now allowed us to begin testing our Medifast Direct platform as a client and lead generation tool that will support our Health Coaches.
We are still in the very early stages of development of this potential new opportunity, but our research supports the idea that if we assign a Health Coach to a customer, there is a much better outcome for everyone.
This testing is an example of our focus to move to an integrated business model for the benefit of our Health Coach partners.
We are optimistic that this alignment will enhance our long-term success and will serve as a springboard for the expansion into a ---+ for our expansion into other markets.
Before I turn the time over to Tim, I'd be remiss if I didn't mention our recent recognition by Forbes.
Medifast, for the second consecutive year, was rated as one of Forbes 100 most trustworthy companies in America.
This is a significant accomplishment, and we are very proud to be recognized on this list.
Honesty and integrity are important components of our mission, and this recognition further validates our company's commitment to financial ethics and corporate integrity.
A special thanks especially to our finance and legal leadership for their hard work and commitment to excellence.
In summary, we continue to make year-over-year progress and expect to see an acceleration of our growth rate in our upcoming quarters in 2017.
We're approaching what will likely be our largest convention ever with a very significant set of deliverables.
The health of our business, our significant cash generation and the strength of our balance sheet puts us in a position to continue enhancing stockholder value through improved results in addition to our existing dividend and share repurchase programs.
With that, I'd like to turn the call over to our CFO, Tim <UNK>.
Thank you, Dan, and good afternoon, everybody.
In the first quarter, revenue of $70.6 million was in line with our expectations.
Take Shape For Life accounted for approximately 82% of revenue.
Medifast Direct accounted for 12.7%.
Franchise Medifast Weight Control Centers accounted for 4.9%, and Medifast Wholesale accounted for 0.4% of net revenue.
Revenue in Take Shape For Life increased 2.3% to $58 million from $56.7 million in the first quarter of the prior year.
As Dan mentioned, there were approximately 13,000 active Health Coaches in the first quarter compared to 12,600 in the same period last year and 12,500 in the fourth quarter of 2016.
Average revenue per active earning Health Coach for the quarter decreased slightly to $4,463 as compared to $4,490 in the first quarter of last year.
Our Medifast Direct revenue decreased 18.3% to $8.9 million as compared to $10.9 million in the first quarter of 2016.
Total Medifast Direct advertising in the quarter decreased 44% to $2.3 million from $4.1 million in the first quarter of 2016.
This decrease is a result of our ongoing initiatives to optimize our advertising spend to acquire a growing number of customers that support long-term profitable growth.
Going forward, our strategy is to gradually shift our emphasis to an integrated business model, driving online customers into our coaching model, thus, gaining a higher lifetime value and minimizing any remaining conflict between our current business units.
Revenue in the Franchise Medifast Weight Control Centers decreased to $3.5 million from $4.2 million in the same period last year.
The decrease in revenue is primarily driven by fewer franchise centers in operation during the period.
We ended the quarter with 37 franchise centers in operation, plus 19 reseller locations compared to 58 centers at the end of the same period last year.
Medifast Wholesale revenue, which is mostly comprised of revenue from health care providers, decreased to $261,000 compared to $497,000 in the prior year period.
Lower revenue is consistent with our previously communicated strategic decision to reduce emphasis on this area of our business based on the significant number of health care providers in our Take Shape For Life coach community and our enforcement of our business partner compliance distribution requirements.
Gross profit for the first quarter of 2017 decreased modestly to $52.9 million compared to $53.2 million in the prior period.
We were pleased to see our gross profit margin as a percentage of net revenue expand by 140 basis points, 74.9% versus 73.5% in the first quarter of 2016.
The increase was driven primarily with price increases and efficiencies in our supply chain operation.
Selling, general and administrative expenses in the first quarter of 2017 were $44.3 million or 62.7% of revenues versus $46.9 million or 64.9% of revenues in the first quarter of last year.
The first quarter of 2016 includes a $1.2 million of restructuring costs, and excluding these costs, SG&A decreased $1.4 million year-over-year.
Adjusted selling, general and administrative expenses as a percentage of net revenue decreased 60 basis points from 63.3% in the first quarter last year compared to 62.7% for the first quarter of 2017.
The decrease in SG&A was primarily a result of reduced and more effective advertising spend in Medifast Direct.
Sales and marketing expense decreased $1.4 million in the first quarter of 2017 as compared to the first quarter of 2016.
Net income in the first quarter of 2017 was $6.1 million or $0.51 per diluted share based on approximately 12 million shares outstanding.
First quarter 2016 net income was $4.3 million or $0.36 per diluted share based on approximately 11.9 million shares outstanding.
Excluding $800,000 of restructuring costs net of taxes, net income in the first quarter of 2016 would have been $5 million or $0.42 per diluted share.
Our effective tax rate was 29.5% compared to 33% in the first quarter of 2016.
The decrease in the effective tax rate was due to the change in accounting for taxes associated with share-based compensation.
Our balance sheet remains very strong with shareholders' equity of $99.2 million and working capital of $80.5 million as of March 31, 2017.
Cash, cash equivalents and investment securities as of March 31, 2017, increased $2.2 million to $79 million compared to $76.8 million at December 31, 2016.
We continue to have approximately 850,000 shares remaining in our repurchase authorization as of March 31, 2017.
Our Board of Directors declared a $0.32 quarterly dividend during the quarter payable on May 9.
Turning to our guidance.
We expect second quarter revenues to be in the range of $72 million to $75 million and earnings per diluted share to be in the range of $0.51 to $0.54 per diluted share.
We are reiterating our 2017 full year guidance.
We expect full year revenue to be in the range of $290 million to $300 million and full year earnings per diluted share to be in the range of $2 to $2.10 per diluted share.
Our fiscal year 2017 guidance assumes a 33% to 34% effective tax rate.
Well, that concludes our operational and financial review.
We appreciate your interest in Medifast, and Dan and I are now available to take your questions.
Operator.
Yes.
So it's a little bit of last year, a little bit of this year.
So last year, you may recall, in the first quarter, we did some restructuring.
So we took out a decent amount of expense from the first quarter into the second quarter.
So you saw that drop.
But all that restructuring cost was pushed into the first quarter, so you had a pretty good drop into the second quarter.
So that's kind of the shift last year.
This year, you have this upcoming convention especially.
It's a really big deal for us.
It's a big event.
And unlike even prior years, we've made investments in systems, investments in the story behind our Take Shape For Life soon to be OPTAVIA group.
So we put ---+ we have a decent amount of costs in the second quarter this year that we didn't have last year, preparing really for, really, a big transformation here in July, and that's really the catalyst that will drive the increased revenue growth in second half.
I think ---+ this is Dan, <UNK>.
I think what I would say is that number goes up and down slightly depending on what's happening related to sponsoring, but in general, it's fairly stable as you've said.
We don't foresee it dropping significantly.
And likely, as we continue to roll out OPTAVIA and come out of the convention, we'd expect as sponsoring increases in the back half of the year that we'd also see productivity potentially adjust up slightly.
But it's a reflection largely of the way our coaches work with their clients.
They're ---+ most of them have multiple clients that they work with over a series of several months, which is why it's a fairly stable number for us.
Yes.
It's the combination of things that are very related.
So we had ---+ as you know, in the fourth quarter, we had some supply challenges, some of our brand-new products, and that had an impact on ---+ some impact on revenue but more have the impact on sponsoring of new coaches.
And so the combination of those 2 things put downward pressure on the productivity.
And then we typically, though, in the fourth quarter ---+ historically, at least, in the fourth quarter, it's the holidays and it's a little bit different productivity anyway.
No, I don't have a number for you.
I think we have a feel for it.
What I can tell you is that we don't have a very robust effort to go back after lapsed customers.
We do some e-mail campaigns for lapsed customers.
And the way we track customers in our system is that once a customer gets an account with us, we measure them as a customer, not a ---+ when ---+ if they come back 6 months from now they're still the same customer.
They don't get recorded as a new customer.
So we could ---+ we have some kind of anecdotal information, I think, that says that we think it's a relatively smaller percentage of our customers in the ---+ my guess would be somewhere in the 10% to 15% range.
But the way we track our customers, way we track lifetime value, all those things, is once we attach an ID to you, you're a customer so that's not like a metric that we look back closely at or a metric that we report.
From an advertising perspective, I think we're actually very pleased with the quarter, and we're pleased what we saw ---+ what we've seen in April and that we've been trying for a long time, as you know, to find that right mix to be able to acquire a customer at a very efficient cost so that, as we go forward, we could afford to attach that customer to a coach, which we know is a better outcome for the customer as far as staying on program.
We know it's the better outcome for us.
It's a more profitable outcome for us.
So if we had maintained our previous spend, it would never have financially made sense to attach a coach and pay a coach for coaching a customer and also pay for the acquisition.
So we're really pleased with what saw in the first quarter, as we had a very good acquisition cost.
We've seen it come through in April as well.
And you're starting to see that trajectory of revenue growth in Med Direct.
You're starting to see that rebound.
We expect to see more of that in the second quarter.
There's ---+ we're developing ---+ I mean, I won't call it an algorithm, but it's tied to performance.
Those coaches who were performing at the right levels, who, in essence, will provide the best kind of support are those who will receive the leads.
I mean, we're at the very beginning stages of this right now and a big part of this is making sure that our coaches understand that we're working with them to make this ---+ and to drive this for their success.
So there can be ---+ it can be a big difference maker in kind of accelerating the growth in our coach model as we do it.
So I think more to come, but I think what we're seeing and what we're understanding about the possibilities are very encouraging.
Well, I'd like to thank you all of you for your interest in Medifast and for your participation in today's call.
We look forward to speaking with you again when we report our second quarter 2017 financial results.
And we wish all of you a pleasant evening.
